TEVA - Teva hits 52-week high on outlook API divestment
2024-01-31 11:34:01 ET
More on Teva Pharmaceutical
- Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)
- Teva: 4 Key Drivers For A 2024 Revival (Upgraded Rating)
- Teva Pharmaceutical Industries Limited (TEVA) Presents at 6th Annual Evercore ISI HealthCONx Conference (Transcript)
- Biggest stock movers today: Plug Power, Paramount Global, Google parent Alphabet, and more
- Teva Pharmaceutical Non-GAAP EPS of $1.00 beats by $0.24, revenue of $4.46B beats by $450M